Sol-Gel Technologies

SLGLNasdaq Israel Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$199.550 M

$60.95 +2.82%

Close of 22 Sept 2026

Revenue

$19.4M

#2996 by revenue

Earnings

-$6.13M

Loss-making

Shares outstanding

2,786,158

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#265PepGenPEPG$206.4M
#266Journey MedicalDERM$204.6M
#267Sol-Gel TechnologiesSLGL$199.6M
#268Veraxa Biotech AG - Post de-SPACVRXA$199.4M
#269Oramed PharmaceuticalsORMP$197.6M

Insiders buying

All insider buying →

3 open-market purchases by officers and directors of Sol-Gel Technologies, worth $3.07M. Grants and option exercises are excluded.

Opaleye Management Inc.$207.4K
3,124 shares at $66.39 on 10 Sept 2026 · filed 14 Sept 2026
Opaleye Management Inc.$2.79M
40,330 shares at $69.19 on 28 Aug 2026 · filed 31 Aug 2026
Opaleye Management Inc.$68.0K
951 shares at $71.50 on 12 Aug 2026 · filed 14 Aug 2026

What if Sol-Gel Technologies were worth as much as…

Open the what-if tool →

Gold $30.2T

$9,234,569

Per share 151,511× higher

Bitcoin $1.74T

$531,965.66

Per share 8,728× higher

Nvidia $5.52T

$1,684,719

Per share 27,641× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Sol-Gel Technologies are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.